An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
This is an Open-Label Rollover Extension Clinical Trial to Evaluate the Long-Term Safety and Efficacy of KT-301 (formerly US-APR2020) in Subjects With CKD IV Who Completed the US-APR2020-01 Study
100 项与 US-APR2020 相关的临床结果
100 项与 US-APR2020 相关的转化医学
100 项与 US-APR2020 相关的专利(医药)
100 项与 US-APR2020 相关的药物交易